Relay Therapeutics Inc (NAS:RLAY)
$ 18.73 -1.27 (-6.35%) Market Cap: 4.08 Bil Enterprise Value: 3.47 Bil PE Ratio: 0 PB Ratio: 5.53 GF Score: 58/100

Relay Therapeutics Inc at TD Cowen Healthcare Conference Transcript

Mar 2, 2026 / 08:10 PM GMT


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

RLAY.OQ - Relay Therapeutics Inc
Relay Therapeutics Inc at TD Cowen Healthcare Conference
Mar 02, 2026 / 08:10PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Welcome once again to the forty-sixth annual TD Cowan Healthcare Conference. I'm Yaron Werber from the TD Cowan, Biotech team. It's a great pleasure to moderate the next fireside chat with Relay Therapeutics. With us today, we have Sanjeev Patel, President and CEO, to his left, Peter Rahmer, Chief, Corporate Development Officer. To his left, Don Bergstrom, President of R&D, and, with us today, Jaynahan as well from our team. So, I think we have a few slides to go through, and then we'll actually start the presentation thereafter in Q&A on, vascular malformations, which is a new and important new area, and then we'll talk about breast cancer.

--------------------------------------------------------------
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot